Control mechanisms in delayed-type hypersensitivity.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D001491:Basophils / Q000276:immunology; D003520:Cyclophosphamide / Q000494:pharmacology; D003864:Depression, Chemical; D003877:Dermatitis, Contact / Q000276:immunology; D004137:Dinitrochlorobenzene / Q000494:pharmacology; D004139:Dinitrofluorobenzene / Q000494:pharmacology; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007108:Immune Tolerance / Q000187:drug effects; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects
D004137:Dinitrochlorobenzene; D003520:Cyclophosphamide; D004139:Dinitrofluorobenzene